The document summarizes that inVentiv Medical Management (iMM) received three accreditations in population health management from URAC, the largest US accrediting body for PHM. The accreditations were for health utilization management, case management, and disease management. This recognizes iMM's commitment to providing high quality, comprehensive population health services to help healthcare providers succeed under value-based care models. iMM can now serve as a single source partner to providers, employers, and payers for population health.

1. NEWS RELEASE
FOR IMMEDIATE RELEASE
Contact:
Laci Foster
inVentiv Medical Management
+1 706 855 0830 x2280
laci.foster@inVentivMM.com
inVentiv Medical Management Receives Two More Accreditations in Population
Health Management
iMM Helps Providers Enter New Era of Value-Based Care by Providing
Comprehensive, Quality Services that Improve Outcomes
CHARLOTTE, N.C. – August 1, 2013 – inVentiv Health Medical Management (iMM)
announced today that it has become part of a select group of companies receiving three
accreditations in Population Health Management (PHM) from a national organization setting
quality standards for U.S. healthcare. PHM has become a centerpiece in improving patient
outcomes under the Affordable Care Act.
iMM received the three accreditations from URAC, the nation’s largest accrediting body for
PHM. Under the federal Affordable Care Act providers are rewarded for the value of the care
they deliver to patients rather than the volume of care. Providers must deliver improved
outcomes at lower costs. PHM helps deliver evidence-based, coordinated care across the
healthcare continuum, from promoting wellness to managing complex chronic diseases.
“As providers sprint to meet the federal requirements under the Affordable Care Act, they can
turn to us as their single source for management of population health,” said Marc Palmer,
CEO of iMM. “For employers, human resources professionals and claims administrators, it is
far easier to manage a single provider that they can count on for the highest quality services,
rather than multiple providers.”
iMM now holds accreditation in Health Utilization Management, Case Management and
Disease Management services from URAC:
• Health Utilization Management: The first accreditation from URAC, received in 2012,
was for the independent, clinical evaluation of the appropriateness, medical need and
efficient use of healthcare services according to evidence-based guidelines and
individual health plan benefits.
• Case Management: One of the two most recent accreditations, effective July 1,
recognizes the quality of iMM’s collaborative care process between a consumer, care
providers and clinical case managers toward the goal of promoting cost-effective
outcomes and a return to health.
• Disease Management: The second of the most recent accreditations, this one
recognizes the high quality of iMM’s delivery and coordination of health interventions
over the long term by nurses who help consumers reduce the financial, emotional and
physical burdens of chronic disease.
“By applying for and receiving Case Management and Disease Management accreditation,
inVentiv Medical Management has demonstrated a commitment to quality healthcare,” said
URAC Chief Operating Officer William Vandervennet. “Quality healthcare is crucial to our
nation’s welfare and it is important to have organizations that are willing to measure

2. NEWS RELEASE
themselves against national standards and undergo rigorous evaluation by an independent
accrediting body.”
iMM employs an in-house medical team of physicians and nurses, as well as dieticians and
social workers, to manage care. These experts tap a proprietary database, the inFinitē
Platform, which enables predictive modeling to inform the coordinated care of individual
patients. iMM delivers services appropriate to the individual, while eliminating gaps in care,
promoting cost effectiveness and creating a seamless experience for consumers.
iMM programs that combine the three accredited services have already shown measurable
success in improving outcomes for patients suffering from some of the most complex, costly
diseases, such as cancer, cardiovascular disease and chronic kidney disease.
About URAC
URAC, an independent, nonprofit organization, is a leader in promoting health care quality
through accreditation and certification programs. URAC's standards keep pace with the rapid
changes in the healthcare system, and provide a mark of distinction for healthcare
organizations to demonstrate their commitment to quality and accountability. Through its
broad-based governance structure and an inclusive standards development process, URAC
ensures that all stakeholders are represented in setting meaningful standards for the
healthcare industry. For more information, visit www.urac.org.
About inVentiv Medical Management
inVentiv Medical Management, an inVentiv Health company, is a leading national provider of
physician-directed, nurse-supported, technology-enabled, population health management
solutions to third party administrators, self-funded and fully insured plans, employer groups,
Accountable Care Organizations (ACOs) and health plans. With a mission of improving
healthcare quality, costs and outcomes, enabled by the fully integrated inFinitē Platform
inVentiv Medical Management delivers seamless clinical interventions and cost management
that support consumers, providers and payers. inVentiv Medical Management is
headquartered in Charlotte, North Carolina. Please visit http://www.inVentivMM.com for more
information.
About inVentiv Health
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and
consulting services to companies seeking to accelerate performance. inVentiv offers
convergent services that deliver extraordinary outcomes to clients whose goal is improving
human life. In 40 countries around the world, inVentiv’s 13,000 employees help clients
rapidly transform promising ideas into commercial reality. inVentiv clients include more than
550 pharmaceutical, biotech and life sciences companies, as well as companies that now
see health as part of their mission. inVentiv Health, Inc. is privately owned by inVentiv Group
Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P.,
Liberty Lane Partners and members of the inVentiv management team. For more
information, visit http://www.inVentivHealth.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause our
performance to differ materially. These forward-looking statements reflect our current views about future events
and are subject to risks, uncertainties and assumptions. We wish to caution readers that certain important factors
may have affected and could in the future affect our actual results and could cause actual results to differ
significantly from those expressed in any forward-looking statement. Such factors include, without limitation: the
impact of our substantial level of indebtedness on our ability to generate sufficient cash to fulfill our obligations
under our existing debt instruments or our ability to incur additional indebtedness; the impact of customer project
delays and cancellations and our ability to sufficiently increase our revenues and manage expenses and capital

3. NEWS RELEASE
expenditures to permit us to fund our operations; the impact of the consummation of any future acquisitions; the
impact of any change in our ratings and the ratings of our debt securities on our relationships with customers,
vendors and other third parties; the impact of any additional leverage we may incur on our ratings and the ratings
of our debt securities; our ability to continue to comply with the covenants and terms of our senior secured credit
facilities and to access sufficient capital under our credit agreement or from other sources of debt or equity
financing to fund our operations; the impact of any default by any of our credit providers; our ability to accurately
forecast costs to be incurred in providing services under fixed price contracts; our ability to accurately forecast
insurance claims within our self- insured programs; the potential impact of pricing pressures on pharmaceutical
manufacturers from healthcare reform initiatives or from changes in the reimbursement policies of third-party
payers; our ability to grow our existing client relationships, obtain new clients and cross-sell our services; the
potential impact of financial, economic, political and other risks, including interest rate and exchange rate risks,
related to conducting business internationally; our ability to successfully operate new lines of business; our ability
to manage our infrastructure and resources to support our growth; our ability to successfully identify new
businesses to acquire, conclude acquisition negotiations and integrate the acquired businesses into our
operation, and achieve the resulting synergies; the resolution of purchase price adjustment disputes in connection
with our recent acquisitions and related impacts; any disruptions, impairments, or malfunctions affecting software
as well as excessive costs or delays that may adversely impact our continued investment in and development of
software; the potential impact of government regulation on us and on our client base; our ability to comply with all
applicable laws as well as our ability to successfully adapt to any changes in applicable laws on a timely and cost
effective basis; our ability to recruit, motivate and retain qualified personnel, including sales representatives; the
possibility that client agreements will be terminated or not renewed; any potential impairment of goodwill or
intangible assets; consolidation in the pharmaceutical industry; changes in trends in the healthcare and
pharmaceutical industries or in pharmaceutical outsourcing, including initiatives by our clients to perform services
we offer internally; our ability to convert backlog into revenue; the potential liability associated with injury to clinical
trial participants; the actual impact of the adoption of certain accounting standards; and our ability to maintain
technological advantages in a variety of functional areas, including sales force automation, electronic claims
surveillance and patient compliance. Holders of our debt instruments are referred to reports provided to investors
from time to time and the offering memoranda provided in connection with the issuance of our notes for further
discussion of these risks and other factors.
# # #